{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:33:37Z","timestamp":1793122417002,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bone.2026.118140","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:12:09Z","timestamp":1792422729000},"page":"118140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inactivation of the polycomb repressive complex 2 (PRC2) in osteoblasts increases post-natal trabecular bone mass and mechanical bone strength"],"prefix":"10.1016","author":[{"given":"Amel","family":"Dudakovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Paradise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Lizeth","family":"Galvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kubrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Pichurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmini J.","family":"Deosthale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian I.","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre J.","family":"van Wijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bone.2026.118140_bb0005","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.mayocp.2022.03.011","article-title":"Skeletal aging","volume":"97","author":"Sfeir","year":"2022","journal-title":"Mayo Clin. Proc."},{"issue":"2","key":"10.1016\/j.bone.2026.118140_bb0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1210\/jc.2011-2332","article-title":"Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives","volume":"97","author":"Baron","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.bone.2026.118140_bb0015","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.clinthera.2015.06.006","article-title":"The pathophysiology and treatment of osteoporosis","volume":"37","author":"Drake","year":"2015","journal-title":"Clin. Ther."},{"key":"10.1016\/j.bone.2026.118140_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112466","article-title":"FDA-approved bone grafts and bone graft substitute devices in bone regeneration","volume":"130","author":"Gillman","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"2","key":"10.1016\/j.bone.2026.118140_bb0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11914-017-0353-4","article-title":"Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy","volume":"15","author":"Leder","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"issue":"6","key":"10.1016\/j.bone.2026.118140_bb0030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/bcp.13766","article-title":"Osteoanabolic and dual action drugs","volume":"85","author":"Tabacco","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2026.118140_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101480","article-title":"Parathyroid hormone (PTH) regulation of metabolic homeostasis: an old dog teaches us new tricks","volume":"60","author":"Rendina-Ruedy","year":"2022","journal-title":"Mol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2026.118140_bb0040","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/JME-18-0173","article-title":"Novel therapies in osteoporosis: PTH-related peptide analogs and inhibitors of sclerostin","volume":"62","author":"Rachner","year":"2019","journal-title":"J. Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2026.118140_bb0045","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-17-0920","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis","volume":"178","author":"Canalis","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bone.2026.118140_bb0050","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.bone.2015.03.011","article-title":"Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease","volume":"81","author":"Gordon","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.bone.2026.118140_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117043","article-title":"Epigenetic regulators controlling osteogenic lineage commitment and bone formation","volume":"181","author":"Dashti P","year":"2024","journal-title":"Bone"},{"issue":"46","key":"10.1016\/j.bone.2026.118140_bb0060","doi-asserted-by":"crossref","first-page":"27604","DOI":"10.1074\/jbc.M115.672345","article-title":"Epigenetic control of skeletal development by the histone methyltransferase Ezh2","volume":"290","author":"Dudakovic","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.bone.2026.118140_bb0065","doi-asserted-by":"crossref","first-page":"12894","DOI":"10.1074\/jbc.RA118.002983","article-title":"Enhancer of zeste homolog 2 (Ezh2) controls bone formation and cell cycle progression during osteogenesis in mice","volume":"293","author":"Dudakovic","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.bone.2026.118140_bb0070","doi-asserted-by":"crossref","first-page":"19001","DOI":"10.1074\/jbc.RA118.003909","article-title":"Loss of histone methyltransferase Ezh2 stimulates an osteogenic transcriptional program in chondrocytes but does not affect cartilage development","volume":"293","author":"Camilleri","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2026.118140_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbrc.2021.06.003","article-title":"Ezh2 knockout in mesenchymal cells causes enamel hyper-mineralization","volume":"567","author":"Kobayashi","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.bone.2026.118140_bb0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/scd.2020.0209","article-title":"Ezh2 is essential for patterning of multiple musculoskeletal tissues but dispensable for tendon differentiation","volume":"30","author":"Pal","year":"2021","journal-title":"Stem Cells Dev."},{"issue":"47","key":"10.1016\/j.bone.2026.118140_bb0085","doi-asserted-by":"crossref","first-page":"24594","DOI":"10.1074\/jbc.M116.740571","article-title":"Enhancer of zeste homolog 2 inhibition stimulates bone formation and mitigates bone loss caused by ovariectomy in skeletally mature mice","volume":"291","author":"Dudakovic","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bone.2026.118140_bb0090","doi-asserted-by":"crossref","first-page":"7877","DOI":"10.1074\/jbc.RA119.011685","article-title":"Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2","volume":"295","author":"Dudakovic","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2026.118140_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115993","article-title":"Multiple pharmacological inhibitors targeting the epigenetic suppressor enhancer of zeste homolog 2 (Ezh2) accelerate osteoblast differentiation","volume":"150","author":"Galvan","year":"2021","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bone.2026.118140_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105155","article-title":"Inhibition of Ezh2 redistributes bivalent domains within transcriptional regulators associated with WNT and Hedgehog pathways in osteoblasts","volume":"299","author":"Carrasco","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bone.2026.118140_bb0105","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/stem.1573","article-title":"EZH2 and KDM6A act as an epigenetic switch to regulate mesenchymal stem cell lineage specification","volume":"32","author":"Hemming","year":"2014","journal-title":"Stem Cells"},{"issue":"12","key":"10.1016\/j.bone.2026.118140_bb0110","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1089\/scd.2015.0384","article-title":"Identification of novel EZH2 targets regulating osteogenic differentiation in mesenchymal stem cells","volume":"25","author":"Hemming","year":"2016","journal-title":"Stem Cells Dev."},{"issue":"1","key":"10.1016\/j.bone.2026.118140_bb0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ncb2139","article-title":"CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells","volume":"13","author":"Wei","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.bone.2026.118140_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41413-020-00116-y","article-title":"Growth differentiation factor 6, a repressive target of EZH2, promotes the commitment of human embryonic stem cells to mesenchymal stem cells","volume":"8","author":"Deng","year":"2020","journal-title":"Bone Res."},{"issue":"3","key":"10.1016\/j.bone.2026.118140_bb0125","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.stemcr.2017.07.016","article-title":"Inhibition of EZH2 promotes human embryonic stem cell differentiation into mesoderm by reducing H3K27me3","volume":"9","author":"Yu","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"6","key":"10.1016\/j.bone.2026.118140_bb0130","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/jbmr.3975","article-title":"\u03b2-Catenin preserves the stem state of murine bone marrow stromal cells through activation of EZH2","volume":"35","author":"Sen","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.118140_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146199","article-title":"FGFR2 accommodates osteogenic cell fate determination in human mesenchymal stem cells","volume":"818","author":"Zhang","year":"2022","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.bone.2026.118140_bb0140","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1096\/fj.201600748R","article-title":"EZH2 deletion in early mesenchyme compromises postnatal bone microarchitecture and structural integrity and accelerates remodeling","volume":"31","author":"Hemming","year":"2017","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bone.2026.118140_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ydbio.2018.09.014","article-title":"Stage-specific roles of Ezh2 and Retinoic acid signaling ensure calvarial bone lineage commitment","volume":"443","author":"Ferguson","year":"2018","journal-title":"Dev. Biol."},{"issue":"2","key":"10.1016\/j.bone.2026.118140_bb0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/mt.2015.152","article-title":"Suppression of EZH2 prevents tnat bi shift of osteoporotic MSC fate to adipocyte and enhances bone formation during osteoporosis","volume":"24","author":"Jing","year":"2016","journal-title":"Mol. Ther."},{"issue":"11","key":"10.1016\/j.bone.2026.118140_bb0155","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.4049\/jimmunol.1501466","article-title":"Cutting edge: EZH2 promotes osteoclastogenesis by epigenetic silencing of the negative regulator IRF8","volume":"196","author":"Fang","year":"2016","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.bone.2026.118140_bb0160","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/MCB.21.13.4330-4336.2001","article-title":"The polycomb-group gene Ezh2 is required for early mouse development","volume":"21","author":"O'Carroll","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.bone.2026.118140_bb0165","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1101\/gad.2019811","article-title":"EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair","volume":"25","author":"Ezhkova","year":"2011","journal-title":"Genes Dev."},{"issue":"6","key":"10.1016\/j.bone.2026.118140_bb0170","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/jbmr.1999.14.6.893","article-title":"Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation\/mineralization potential","volume":"14","author":"Wang","year":"1999","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2026.118140_bb0175","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25\u202fyears of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.bone.2026.118140_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"13","key":"10.1016\/j.bone.2026.118140_bb0185","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/MCB.21.13.4330-4336.2001","article-title":"The polycomb-group gene Ezh2 is required for early mouse development","volume":"21","author":"O'Carroll","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.bone.2026.118140_bb0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1101\/gad.2019811","article-title":"EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair","volume":"25","author":"Ezhkova","year":"2011","journal-title":"Genes Dev."},{"issue":"13685","key":"10.1016\/j.bone.2026.118140_bb0195","article-title":"EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy","volume":"7","author":"Lui","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bone.2026.118140_bb0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ni876","article-title":"Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement","volume":"4","author":"Su","year":"2003","journal-title":"Nat. Immunol."},{"issue":"16","key":"10.1016\/j.bone.2026.118140_bb0205","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1242\/dev.02480","article-title":"Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors","volume":"133","author":"Rodda","year":"2006","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.bone.2026.118140_bb0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1242\/dev.121.2.273","article-title":"The eed mutation disrupts anterior mesoderm production in mice","volume":"121","author":"Faust","year":"1995","journal-title":"Development"},{"issue":"18","key":"10.1016\/j.bone.2026.118140_bb0215","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1101\/gad.246124.114","article-title":"Repression of the soma-specific transcriptome by Polycomb-repressive complex 2 promotes male germ cell development","volume":"28","author":"Mu","year":"2014","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.bone.2026.118140_bb0220","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/2159-8290.CD-19-0152","article-title":"Loss of EZH2 reprograms BCAA metabolism to drive leukemic transformation","volume":"9","author":"Gu","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bone.2026.118140_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13685","article-title":"EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy","volume":"7","author":"Lui","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bone.2026.118140_bb0230","doi-asserted-by":"crossref","first-page":"13361","DOI":"10.1038\/s41598-022-17579-0","article-title":"MicroRNA-101a enhances trabecular bone accrual in male mice","volume":"12","author":"Dudakovic","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bone.2026.118140_bb0235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jbm4.10035","article-title":"Cx43 overexpression in osteocytes prevents osteocyte apoptosis and preserves cortical bone quality in aging mice","volume":"2","author":"Davis","year":"2018","journal-title":"JBMR Plus"},{"issue":"7","key":"10.1016\/j.bone.2026.118140_bb0240","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.118140_bb0245","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s40610-017-0064-8","article-title":"Epigenetic control of osteoblast differentiation by enhancer of zeste homolog 2 (EZH2)","volume":"3","author":"Dudakovic","year":"2017","journal-title":"Curr. Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.bone.2026.118140_bb0250","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nchembio.2304","article-title":"An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED","volume":"13","author":"Qi","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bone.2026.118140_bb0255","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nchembio.2306","article-title":"The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex","volume":"13","author":"He","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"7427","key":"10.1016\/j.bone.2026.118140_bb0260","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bone.2026.118140_bb0265","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.molcel.2008.11.004","article-title":"Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms","volume":"32","author":"Margueron","year":"2008","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bone.2026.118140_bb0270","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2008.10.016","article-title":"EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency","volume":"32","author":"Shen","year":"2008","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.bone.2026.118140_bb0275","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.molcel.2018.03.019","article-title":"Distinct stimulatory mechanisms regulate the catalytic activity of Polycomb Repressive Complex 2","volume":"70","author":"Lee","year":"2018","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bone.2026.118140_bb0280","article-title":"Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2026.118140_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116377","article-title":"Tetracyclines and bone: unclear actions with potentially lasting effects","volume":"159","author":"Warner","year":"2022","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2026.118140_bb0290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jbmr.3863","article-title":"EZH2 supports osteoclast differentiation and bone resorption via epigenetic and cytoplasmic targets","volume":"35","author":"Adamik","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"10.1016\/j.bone.2026.118140_bb0295","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25\u202fyears of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226003662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:50:38Z","timestamp":1793119838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226003662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":59,"alternative-id":["S8756328226003662"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.118140","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivation of the polycomb repressive complex 2 (PRC2) in osteoblasts increases post-natal trabecular bone mass and mechanical bone strength","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.118140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118140"}}